Back to GetFilings.com



Table of Contents

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 10-Q

 


 

x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15 (d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the Quarterly Period Ended June 30, 2004

 

OR

 

¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934

 

For the transition period from              to

 

Commission File Number 000-24435

 


 

 

MICROSTRATEGY INCORPORATED

(Exact name of registrant as specified in its charter)

 


 

Delaware

(State of incorporation)

 

1861 International Drive, McLean, VA

(Address of Principal Executive Offices)

 

22102

(Zip Code)

 

51-0323571

(I.R.S. Employer

Identification Number)

 

Registrant’s telephone number, including area code: (703) 848-8600

 


 

Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    Yes  x    No  ¨

 

Indicate by check mark whether the registrant is an accelerated filer (as defined in Rule 12b-2 of the Exchange Act).    Yes  x    No  ¨

 

The number of shares of the registrant’s class A common stock and class B common stock outstanding on August 1, 2004 was 12,517,701 and 3,549,399, respectively.

 



Table of Contents

MICROSTRATEGY INCORPORATED

 

FORM 10-Q

 

TABLE OF CONTENTS

 

         Page

PART I.

 

FINANCIAL INFORMATION

    

Item 1.

 

Financial Statements

    
   

Consolidated Balance Sheets as of June 30, 2004 (unaudited) and December 31, 2003

   1
   

Consolidated Statements of Operations For the Three Months Ended June 30, 2004 (unaudited) and 2003 (unaudited).

   2
   

Consolidated Statements of Operations For the Six Months Ended June 30, 2004 (unaudited) and 2003 (unaudited).

   3
   

Consolidated Statements of Cash Flows For the Six Months Ended June 30, 2004 (unaudited) and 2003 (unaudited).

   4
   

Notes to Consolidated Financial Statements (unaudited).

   5

Item 2.

 

Management’s Discussion and Analysis of Financial Condition and Results of Operations

   12

Item 3.

 

Quantitative and Qualitative Disclosures About Market Risk.

   30

Item 4.

 

Controls and Procedures.

   31

PART II.

 

OTHER INFORMATION

    

Item 1.

 

Legal Proceedings

   32

Item 5.

 

Other Information.

   33

Item 6.

 

Exhibits and Reports on Form 8-K.

   33


Table of Contents

PART I. FINANCIAL INFORMATION

 

ITEM 1. FINANCIAL STATEMENTS

 

MICROSTRATEGY INCORPORATED

CONSOLIDATED BALANCE SHEETS

(in thousands, except per share data)

 

    

June 30,

2004


   

December 31,

2003


 
     (unaudited)        

Assets

                

Current assets:

                

Cash and cash equivalents

   $ 60,817     $ 51,882  

Restricted cash

     722       747  

Accounts receivable, net

     27,456       30,993  

Prepaid expenses and other current assets

     5,055       3,888  

Deferred tax assets, net

     1,726       1,807  
    


 


Total current assets

     95,776       89,317  
    


 


Property and equipment, net

     16,198       16,113  

Capitalized software development costs, net

     3,979       3,693  

Long-term investments

     26,353       —    

Deposits and other assets

     3,407       1,984  

Deferred tax assets, net

     3,416       3,686  
    


 


Total assets

   $ 149,129     $ 114,793  
    


 


Liabilities and Stockholders’ Equity

                

Current liabilities:

                

Accounts payable and accrued expenses

   $ 13,562     $ 12,768  

Accrued compensation and employee benefits

     15,831       17,968  

Accrued restructuring costs

     2,030       2,599  

Deferred revenue and advance payments

     40,626       28,374  
    


 


Total current liabilities

     72,049       61,709  
    


 


Deferred revenue and advance payments

     2,299       2,750  

Other long-term liabilities

     4,126       2,443  

Accrued restructuring costs

     2,654       3,544  
    


 


Total liabilities

     81,128       70,446  
    


 


Commitments and Contingencies

                

Stockholders’ Equity:

                

Preferred stock undesignated, par value $0.001 per share, 4,971 shares authorized, no shares issued or outstanding

     —         —    

Class A common stock, par value $0.001 per share, 330,000 shares authorized, 12,518 and 12,362 shares issued and outstanding, respectively

     13       12  

Class B common stock, par value $0.001 per share, 165,000 shares authorized, 3,549 and 3,604 shares issued and outstanding, respectively

     4       4  

Additional paid-in capital

     390,037       387,625  

Accumulated other comprehensive income

     2,054       2,619  

Accumulated deficit

     (324,107 )     (345,913 )
    


 


Total stockholders’ equity

     68,001       44,347  
    


 


Total liabilities and stockholders’ equity

   $ 149,129     $ 114,793  
    


 


 

The accompanying notes are an integral part of these Consolidated Financial Statements.

 

1


Table of Contents

MICROSTRATEGY INCORPORATED

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

    

Three Months Ended

June 30,


 
     2004

    2003

 

Revenues:

                

Product licenses

   $ 18,323     $ 19,637  

Product support and other services

     31,561       23,996  
    


 


Total revenues

     49,884       43,633  
    


 


Cost of revenues:

                

Product licenses

     870       739  

Product support and other services

     7,269       6,419  
    


 


Total cost of revenues

     8,139       7,158  
    


 


Gross profit

     41,745       36,475  
    


 


Operating expenses:

                

Sales and marketing

     15,538       14,279  

Research and development

     6,516       7,798  

General and administrative

     7,503       7,963  

Restructuring and impairment charges

     —         1,699  

Amortization of intangible assets

     17       18  
    


 


Total operating expenses

     29,574       31,757  
    


 


Income from operations

     12,171       4,718  

Financing and other (expense) income:

                

Interest income

     174       281  

Interest expense, including discount amortization expense on notes payable of $0 and $883, respectively

     (11 )     (2,049 )

Loss on investments

     (85 )     —    

Loss on early extinguishment of notes payable

     —         (858 )

Other (expense) income, net

     (241 )     133  
    


 


Total financing and other (expense) income

     (163 )     (2,493 )
    


 


Income before income taxes

     12,008       2,225  

Provision (benefit) for income taxes

     581       (71 )
    


 


Net income

   $ 11,427     $ 2,296  
    


 


Basic earnings per share

   $ 0.71     $ 0.16  
    


 


Diluted earnings per share

   $ 0.67     $ 0.15  
    


 


Basic weighted average shares outstanding

     16,056       14,088  
    


 


Diluted weighted average shares outstanding

     17,128       14,940  
    


 


 

The accompanying notes are an integral part of these Consolidated Financial Statements.

 

2


Table of Contents

MICROSTRATEGY INCORPORATED

CONSOLIDATED STATEMENTS OF OPERATIONS

(in thousands, except per share data)

(unaudited)

 

    

Six Months Ended

June 30,


 
     2004

    2003

 

Revenues:

                

Product licenses

   $ 37,134     $ 36,166  

Product support and other services

     61,856       44,902  
    


 


Total revenues

     98,990       81,068  
    


 


Cost of revenues:

                

Product licenses

     1,714       1,529  

Product support and other services

     14,180       12,377  
    


 


Total cost of revenues

     15,894       13,906  
    


 


Gross profit

     83,096       67,162  
    


 


Operating expenses:

                

Sales and marketing

     31,944       26,962  

Research and development

     13,246       14,731  

General and administrative

     15,456       15,147  

Restructuring and impairment charges

     —         1,699  

Amortization of intangible assets

     35       148  
    


 


Total operating expenses

     60,681       58,687  
    


 


Income from operations

     22,415       8,475  

Financing and other income (expense):

                

Interest income

     289       371  

Interest expense, including discount amortization expense on notes payable of $0 and $1,856, respectively

     (25 )     (4,347 )

Loss on investments

     (85 )     —    

Loss on early extinguishment of notes payable

     —         (840 )

Other income, net

     565       95  
    


 


Total financing and other income (expense)

     744       (4,721 )
    


 


Income before income taxes

     23,159       3,754  

Provision for income taxes

     1,353       793  
    


 


Net income

   $ 21,806     $ 2,961  
    


 


Basic earnings per share

   $ 1.36     $ 0.21  
    


 


Diluted earnings per share

   $ 1.27     $ 0.20  
    


 


Basic weighted average shares outstanding

     16,033       13,939  
    


 


Diluted weighted average shares outstanding

     17,190       14,500  
    


 


 

The accompanying notes are an integral part of these Consolidated Financial Statements.

 

3


Table of Contents

MICROSTRATEGY INCORPORATED

CONSOLIDATED STATEMENTS OF CASH FLOWS

(in thousands)

 

    

Six months ended

June 30,


 
     2004